SONIA MARLEN ESCANDON RIVERA

Dr. SONIA MARLEN ESCANDON RIVERA

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2012 in Journal of Natural Products
Verified
Journal Article
Closed access
SRSONIA MARLEN ESCANDON RIVERA
SONIA MARLEN ESCANDON RIVERA
Martín González-AndradeMartín González-Andrade
Martín González-Andrade
RBRobert Bye
Robert Bye
ELEdelmira Linares
Edelmira Linares
ANAndrés Navarrete
Andrés Navarrete
Rachel MataRachel Mata
Rachel Mata

11 February 2013 in Journal of Natural Products
Verified
Journal Article
Closed access
Rachel MataRachel Mata
Rachel Mata
SCSol Cristians
Sol Cristians
SRSONIA MARLEN ESCANDON RIVERA
SONIA MARLEN ESCANDON RIVERA
KJKrutzkaya Juárez-Reyes
Krutzkaya Juárez-Reyes
IRIsabel Rivero-Cruz
Isabel Rivero-Cruz

1 April 2018 in Phytochemistry
Verified
Journal Article
Closed access
Daniel Genaro Rosas-RamirezDaniel Genaro Rosas-Ramirez
Daniel Genaro Rosas-Ramirez
SRSONIA MARLEN ESCANDON RIVERA
SONIA MARLEN ESCANDON RIVERA
RPRogelio Pereda-Miranda
Rogelio Pereda-Miranda

10 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
SRSONIA MARLEN ESCANDON RIVERA
SONIA MARLEN ESCANDON RIVERA
Rachel MataRachel Mata
Rachel Mata
Adolfo Andrade-CettoAdolfo Andrade-Cetto
Adolfo Andrade-Cetto
Like in many developing countries, in Mexico, the use of medicinal plants is a common practice. Based on our own field experience, there are at least 800 plants used for treating diabetes nowadays. Thus, their investigation is essential. In this context, this work aims to provide a comprehensive and critical review of the molecules isolated from Mexican hypoglycemic plants, including their source and target tested. In the last few years, some researchers have focused on the study of Mexican hypoglycemic plants. Most works describe the hypoglycemic effect or the mechanism of action of the whole extract, as well as the phytochemical profile of the tested extract. Herein, we analyzed 85 studies encompassing 40 hypoglycemic plants and 86 active compounds belonging to different classes of natural products: 28 flavonoids, 25 aromatic compounds, other than flavonoids, four steroids, 23 terpenoids, 4 oligosaccharides, and 1 polyalcohol. These compounds have shown to inhibit α-glucosidases, increase insulin secretion levels, increase insulin sensitivity, and block hepatic glucose output. Almost half of these molecules are not common metabolites, with a narrow taxonomic distribution, which makes them more interesting as lead molecules. Altogether, this analysis provides a necessary inventory useful for future testing of these active molecules against different hypoglycemic targets, to get a better insight into the already described mechanisms, and overall, to contribute to the knowledge of Mexican medicinal plants.

1 November 2017 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Open access
Adolfo Andrade-CettoAdolfo Andrade-Cetto
Adolfo Andrade-Cetto
SRSONIA MARLEN ESCANDON RIVERA
SONIA MARLEN ESCANDON RIVERA
GTGerado Mata Torres-Valle
Gerado Mata Torres-Valle
LQLeovigildo Quijano
Leovigildo Quijano
Type 2 diabetes is a major health problem in Mexico, as it is in other countries, is a chronic condition that develops when the body cannot produce enough insulin or cannot use it appropriately. Both insulin deficiency and insulin resistance lead to high blood glucose levels. In Mexico, people with diabetes are known to use the decoction of red mangrove (Rhizophora mangle L., Rhizophoraceae) bark to control blood glucose levels. Therefore, in this study, we sought to investigate the chronic hypoglycemic and hypolipidemic effects of R. mangle; we also elucidate some of the major phytochemical compounds of R. mangle. To analyze the hypoglycemic and hypolipidemic effects, we used rats with streptozotocin–nicotinamide-induced hyperglycemia; the rats were classified into four groups (six rats each), based on the treatment given, as follows: group 1, non-hyperglycemic control; group 2, hyperglycemic control; group 3, glibenclamide (5 mg/kg body weight); and group 4, Rhizophora ethanol–water extract (90 mg/kg). The extract or glibenclamide was orally administered, dissolved in 1.5 ml of physiological NaCl-solution, twice a day (in the morning and in the evening) over a period of 42 days. The methanolic extract was used to elucidate the main compounds present in R. mangle via conventional phytochemical methods, such as TLC, HLPC, UPLC–DAD–MS, and NMR. The following compounds were detected: cinchonains Ia and Ib, catechin-3-O-rhamnopyranoside, epicatechin, lyoniside, and nudiposide. The daily administration of Rhizophora ethanol–water extract, similar to the traditional usage to control type 2 diabetes, was shown to exert chronic hypoglycemic and hypolipidemic effects. This effect may be associated whit the constituents in the extract. These findings suggest that R. mangle and its constituents could be potentially used to treat type 2 diabetes

1 October 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Fernanda Artemisa Espinoza-HernándezFernanda Artemisa Espinoza-Hernández
Fernanda Artemisa Espinoza-Hernández
Adolfo Andrade-CettoAdolfo Andrade-Cetto
Adolfo Andrade-Cetto
SRSONIA MARLEN ESCANDON RIVERA
SONIA MARLEN ESCANDON RIVERA
GVGerardo Mata Torres Valle
Gerardo Mata Torres Valle
Rachel MataRachel Mata
Rachel Mata